Doctor Akihiro Nakamura
Iwate Prefectural Central Hospital, Morioka (Japan)
Impact of pemafibrate on lipid profile and insulin resistance in patients with statin-treated coronary artery disease with metabolic syndrome
Event: ESC Congress 2023
Topic: Lipid-Lowering Agents
Session: Hypertriglyceridemia treatment: CEPT, icosapent ethyl, and fibrates
Efficacy and safety of pemafibrate versus bezafibrate in coronary artery disease patients receiving statin treatment: a randomized, open-label, cross-over study
Event: ESC Congress 2022
Topic: Lipid-Lowering Agents
Session: Current issues in lipid-lowering therapy
Effects of evolocumab on plasma levels of proprotein convertase subtilisin/kexin type 9 and lipoprotein(a) in acute myocardial infarction
Event: ESC Congress 2020
Topic: Lipid-Lowering Agents
Session: Pharmacology and Pharmacotherapy ePosters
ESC 365 is supported by
